You are here

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Brugge, , 8000 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Partial Epilepsy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
16 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients must be diagnosed with partial epilepsy and have experienced at least 2
partial seizures (simple partial, complex partial or partial seizure with secondary
generalization) in the past year with one in the past 6 months.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Treatable causes of seizures, for example identified etiologies including metabolic,
neoplastic or active infectious origin.

- Primary generalized seizures.

NCT00280059
Pfizer
Completed
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Partial Epilepsies, Complex Partial Epilepsy
NCT00143143
All Genders
18+
Years
Multiple Sites
Seizures, Partial Epilepsies, Complex Partial Epilepsy, Generalized Epilepsy, Epilepsy
NCT00319501
All Genders
2+
Years
Multiple Sites
Partial Epilepsy
NCT00141414
All Genders
18+
Years
Multiple Sites
Partial Epilepsy
NCT00280059
All Genders
16+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now